Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Fibrotic Focus as a Prognostic Marker in Breast Cancer

NCT04122131 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT04122131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04122131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Fibrotic Focus as a Prognostic Marker in Breast Cancer
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2019
Completion date
November 30, 2023
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer